Catalent

$109.97 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Catalent

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.

Stock Analysis

last close $109.97
1-mo return 5.1%
3-mo return 15.8%
avg daily vol. 975.28T
52-week high 142.64
52-week low 86.34
market cap. $19.7B
forward pe 27.8
annual div. -
roe 12.3%
ltg forecast 15.5%
dividend yield -
annual rev. $4.7B
inst own. -
baraka

Subscribe now for daily local and international financial news

Subscribe